Joan Clària
Grup de recerca
- Inflamació i malaltia hepàtica Group leader (R4)
Publicacions destacades
-
Essential lipid autacoids rewire mitochondrial energy efficiency in metabolic dysfunction-associated fatty liver disease
Autors:Referència: Hepatology 2023. -
Mitochondrial dysfunction governs immunometabolism in leukocytes of patients with acute-on-chronic liver failure
Autors:Referència: Journal Of Hepatology 2022. -
Untargeted lipidomics uncovers lipid signatures distinguishing severe versus moderate forms of acutely decompensated cirrhosis
Autors:Referència: Journal Of Hepatology 2021. -
Stimulation of soluble guanylate cyclase exerts antiinflammatory actions in the liver through a VASP/NF-κB/NLRP3 inflammasome circuit
Autors:Referència: Proceedings Of The National Academy Of Sciences Of The United States Of America 2020. -
Albumin internalizes and inhibits endosomal TLR signaling in leukocytes from patients with decompensated cirrhosis
Autors:Referència: Science Translational Medicine 2020. -
Targeted lipidomics reveals extensive changes in circulating lipid mediators in patients with acutely decompensated cirrhosis
Autors:Referència: Journal Of Hepatology 2020. -
Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF
Autors:Referència: Journal Of Hepatology 2020. -
Oxidized Albumin Triggers a Cytokine Storm in Leukocytes Through P38 Mitogen-Activated Protein Kinase: Role in Systemic Inflammation in Decompensated Cirrhosis
Autors:Referència: Hepatology 2018. -
Inhibition of soluble epoxide hydrolase modulates inflammation and autophagy in obese adipose tissue and liver: Role for omega-3 epoxides
Autors:Referència: Proceedings Of The National Academy Of Sciences Of The United States Of America 2015. -
Resolvins, Specialized Proresolving Lipid Mediators, and Their Potential Roles in Metabolic Diseases
Autors:Referència: Cell Metabolism 2014.
Projectes destacats
-
Investigació hepática: recerca bàsica i experimental
Investigador/a principal: Joan Claria EnrichFinançador: Generalitat de CatalunyaCodi: 2021-SGR-01323Durada: 01/01/2022 - 31/12/2024 -
DECISION (Decompensated cirrhosis: identification of new combinatorial therapies based on systems approaches)
Investigador/a principal: Joan Claria EnrichFinançador: European CommissionCodi: CE-H2020-SC1_2019_2sDurada: 01/06/2020 - 31/10/2023 -
MICROBiome-based biomarkers to PREDICT decompensation of liver cirrhosis and treatment response
Investigador/a principal: Joan Claria Enrich, Pere Gines GibertFinançador: European CommissionCodi: CE_H2020-SC1_18_1sDurada: 01/01/2019 - 31/03/2025 -
Mecanismos moleculares determinantes de la resolución inadecuada de la inflamación en tejido adiposo obeso. Nuevas oportunidades en la prevención de comorbilidades metabolicas.
Investigador/a principal: Joan Claria EnrichFinançador: Ministerio de Economía y CompetitividadCodi: SAF2015-63674-RDurada: 01/01/2016 - 31/12/2019 -
Identification of novel modulators of chronic inflammation in prevalent diseases: unveiling divergent mechanisms of disease
Investigador/a principal: Joan Claria EnrichFinançador: Instituto de Salud Carlos IIICodi: PIE14/00045Durada: 01/01/2015 - 31/12/2017